mTORC1

You have access
Adenosine Inhibits Cholangiocarcinoma by a Concurrent Activation of AMPK and mTORC1 Signaling Pathways
JOMNARONG LERTSUWAN, JISNUSON SVASTI and JUTAMAAD SATAYAVIVAD

Anticancer Research March 2026, 46 (3) 1449-1460; DOI: https://doi.org/10.21873/anticanres.18040
Open Access
Cancer Stem Cells in Glioblastoma: The Role of the mTOR Pathway
MONICA C. MUREB, SABRINA L. ZELLER, HAYLEN T. ROSBERGER, ERIS SPIROLLARI, MOHAN DAS, SIMON J. HANFT, CHIRAG D. GANDHI and MEENA JHANWAR-UNIYAL

Anticancer Research July 2025, 45 (7) 2697-2709; DOI: https://doi.org/10.21873/anticanres.17640
You have access
mTORC1 and mTORC2 Expression Levels in Oral Squamous Cell Carcinoma: An Immunohistochemical and Clinicopathological Study
GORO KAWASAKI, TOMOFUMI NARUSE, KOHEI FURUKAWA and MASAHIRO UMEDA

Anticancer Research March 2018, 38 (3) 1623-1628;
You have access
Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma
XULU YE, QILIANG ZHOU, YOSHIFUMI MATSUMOTO, MASATO MORIYAMA, SHUN KAGEYAMA, MASAAKI KOMATSU, SEIJIRO SATOH, MASANORI TSUCHIDA and YASUO SAIJO

Anticancer Research November 2016, 36 (11) 6021-6029;
You have access
Involvement of mTOR Signaling Pathways in Regulating Growth and Dissemination of Metastatic Brain Tumors via EMT
AMANDA KWASNICKI, DHRUVE JEEVAN, ALEX BRAUN, RAJ MURALI and MEENA JHANWAR-UNIYAL

Anticancer Research February 2015, 35 (2) 689-696;

Main menu